A detailed history of Chilton Capital Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Chilton Capital Management LLC holds 20,000 shares of NVO stock, worth $1.7 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
20,000
Previous 22,116 9.57%
Holding current value
$1.7 Million
Previous $3.16 Million 24.56%
% of portfolio
0.1%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $251,952 - $307,708
-2,116 Reduced 9.57%
20,000 $2.38 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $245,420 - $293,820
2,000 Added 9.94%
22,116 $3.16 Million
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $11,844 - $15,766
116 Added 0.58%
20,116 $2.58 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $903,670 - $1.98 Million
9,937 Added 98.75%
20,000 $1.82 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $9,826 - $10,876
63 Added 0.63%
10,063 $1.63 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $5,923 - $6,530
-93 Reduced 0.92%
10,000 $694,000
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $5,444 - $6,318
93 Added 0.93%
10,093 $661,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $24,730 - $32,390
-500 Reduced 4.76%
10,000 $602,000
Q3 2019

Nov 15, 2019

SELL
$47.54 - $53.43 $23,770 - $26,715
-500 Reduced 4.55%
10,500 $543,000
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $46,790 - $52,470
1,000 Added 10.0%
11,000 $561,000
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $3,245 - $3,684
-70 Reduced 0.7%
10,000 $523,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $3,100 - $3,529
70 Added 0.7%
10,070 $464,000
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $411,500 - $492,200
10,000
10,000 $482,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.